You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 18 February 2025

Sec. Pharmacology of Anti-Cancer Drugs

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1560529

Corrigendum: The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic prediction model

  • Department of Hepatobiliary Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China

Article metrics

View details

811

Views

271

Downloads

In the published article, there was an error in Figure 13 as published. Due to a data format inconsistency between CSV and TXT files during analysis, an undetected empty row in the header resulted in a misalignment of data. This affected the gene names on the y-axis and cell types on the x-axis, causing a one-row shift in visualization, which led to incorrect matching of color representation with corresponding samples. The corrected Figure 13 and its caption appear below.

FIGURE 13

FIGURE 13

Differential expression analysis of prognostic genes in pancreatic cell lines (A–E). The relative mRNA expression levels of KRTCAP2, NENF, PSAP, MRPL41, and S100A16 were quantified by qRT-PCR in pancreatic cancer cell line PANC-1 and normal pancreatic epithelial cell line hTERT-HPNE.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

pancreatic ductal adenocarcinoma, epigenetic regulation, single-cell RNA sequencing, machine learning, prognostic model, tumor microenvironment, drug sensitivity

Citation

Fu K, Su J, Zhou Y, Chen X and Hu X (2025) Corrigendum: The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic prediction model. Front. Pharmacol. 16:1560529. doi: 10.3389/fphar.2025.1560529

Received

14 January 2025

Accepted

27 January 2025

Published

18 February 2025

Volume

16 - 2025

Edited and reviewed by

Dawei Chen, University of Kiel, Germany

Updates

Copyright

*Correspondence: Xiao Hu,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics